Novo Nordisk's market cap is currently ―. The company's EPS TTM is kr18.67; its P/E ratio is 47.35; and it has a dividend yield of 1.06%. Novo Nordisk is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is kr5.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	kr 65.86B	kr 53.37B	-	kr 45.57B	kr 41.27B
Gross Profit	kr 55.85B	kr 45.19B	-	kr 38.37B	kr 35.20B
EBIT	-	-	-	kr 21.76B	kr 20.05B
EBITDA	-	-	-	kr 23.80B	kr 21.68B
Net Income Common Stockholders	kr 21.96B	kr 19.81B	-	kr 14.40B	kr 13.32B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 30.23B	kr 27.77B	kr 23.57B	kr 37.47B	kr 31.04B
Total Assets	kr 314.49B	kr 250.03B	kr 241.26B	kr 242.84B	kr 218.93B
Total Debt	kr 27.01B	kr 25.52B	kr 25.78B	kr 25.97B	kr 25.43B
Net Debt	kr -3.22B	kr -2.25B	kr 2.21B	kr -11.50B	kr -5.60B
Total Liabilities	kr 377.58B	kr 170.15B	kr 157.77B	kr 166.16B	kr 144.48B
Stockholders Equity	kr 106.56B	kr 79.87B	kr 83.49B	kr 76.68B	kr 74.45B
Cash Flow	-
Free Cash Flow	kr -6.88B	kr 25.01B	-	kr 20.01B	kr 21.39B
Operating Cash Flow	kr 9.55B	kr 29.81B	-	kr 24.24B	kr 23.96B
Investing Cash Flow	kr -14.72B	kr -6.65B	-	kr -4.96B	kr -4.20B
Financing Cash Flow	kr -10.12B	kr -20.62B	-	kr -14.56B	kr -10.43B

Currency in DKK

Novo Nordisk Earnings and Revenue History

Income Statement >

Novo Nordisk Debt to Assets

Balance Sheet >

Novo Nordisk Cash Flow

Cash Flow >

Novo Nordisk Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing